Abstract
Background: Congenital hypogonadotropic hypogonadism (CHH) is a heterogeneous disorder characterized by delayed or loss of puberty and infertility due to functional deficiency in the hypothalamic gonadotropin-releasing hormone (GnRH). CHH can be classified into 2 subtypes on the basis of olfaction: Kallmann syndrome and normosmic CHH (nCHH). The spectrum of genetic variants causing CHH is continually expanding. Here, we recruited a consanguineous Pakistani family having 2 male and 2 female infertile patients diagnosed with idiopathic nCHH. Aims: The aim of this study was to investigate the genetic cause of nCHH in the family. Methods: Clinical and physical analyses were performed for the patients. Genetic analysis was carried out using whole exome and Sanger sequencing. Results: Clinical and physical investigations confirmed low levels of gonadotropins and failure of secondary sexual development in the patients. Genetic analysis identified a novel nonsense mutation (chr4: g.68619942G>A, c.112C>T, p.Arg38*) in the gonadotropin-releasing hormone receptor gene (GNRHR) recessively co-segregating with nCHH in this family. All the patients are homozygous and their parents are heterozygous carriers, while normal siblings are heterozygous carriers or wild-type for this mutation, indicating that the identified mutation is pathogenic for nCHH in the family. Conclusion: We report the first homozygous nonsense mutation in the GNRHR gene (chr4: g. 68619942G>A, c.112C>T, p. Arg38*) that is associated with familial nCHH. Hence, our study displayed a good correlation of the genotype and phenotype of nCHH patients.
References
1.
Kim
SH
. Congenital Hypogonadotropic Hypogonadism and Kallmann Syndrome: Past, Present, and Future
. Endocrinol Metab (Seoul)
. 2015
Dec
;30
(4
):456
–66
.
[PubMed]
2093-596X2.
Fraietta
R
, Zylberstejn
DS
, Esteves
SC
. Hypogonadotropic hypogonadism revisited
. Clinics (São Paulo)
. 2013
;68
(S1
Suppl 1
):81
–8
.
[PubMed]
1807-59323.
Antelli
A
, Baldazzi
L
, Balsamo
A
, Pirazzoli
P
, Nicoletti
A
, Gennari
M
, et al. Two novel GnRHR gene mutations in two siblings with hypogonadotropic hypogonadism
. Eur J Endocrinol
. 2006
Aug
;155
(2
):201
–5
.
[PubMed]
0804-46434.
Seminara
SB
, Hayes
FJ
, Crowley
WF
Jr. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann’s syndrome): pathophysiological and genetic considerations
. Endocr Rev
. 1998
Oct
;19
(5
):521
–39
.
[PubMed]
0163-769X5.
Costa
EM
, Bedecarrats
GY
, Mendonca
BB
, Arnhold
IJ
, Kaiser
UB
, Latronico
AC
. Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction
. J Clin Endocrinol Metab
. 2001
Jun
;86
(6
):2680
–6
.
[PubMed]
0021-972X6.
Wang
Y
, Gong
C
, Qin
M
, Liu
Y
, Tian
Y
. Clinical and genetic features of 64 young male paediatric patients with congenital hypogonadotropic hypogonadism
. Clin Endocrinol (Oxf)
. 2017
Dec
;87
(6
):757
–66
.
[PubMed]
0300-06647.
Correa-Silva
SR
, Fausto
JD
, Kizys
MM
, Filipelli
R
, Marco Antonio
DS
, Oku
AY
, et al. A novel GNRHR gene mutation causing congenital hypogonadotrophic hypogonadism in a Brazilian kindred
. J Neuroendocrinol
. 2018
Dec
;30
(12
):e12658
.
[PubMed]
0953-81948.
Maione
L
, Dwyer
AA
, Francou
B
, Guiochon-Mantel
A
, Binart
N
, Bouligand
J
, et al. GENETICS IN ENDOCRINOLOGY: Genetic counseling for congenital hypogonadotropic hypogonadism and Kallmann syndrome: new challenges in the era of oligogenism and next-generation sequencing
. Eur J Endocrinol
. 2018
Mar
;178
(3
):R55
–80
.
[PubMed]
0804-46439.
Sarfati
J
, Guiochon-Mantel
A
, Rondard
P
, Arnulf
I
, Garcia-Piñero
A
, Wolczynski
S
, et al. A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes
. J Clin Endocrinol Metab
. 2010
Feb
;95
(2
):659
–69
.
[PubMed]
0021-972X10.
Gianetti
E
, Hall
JE
, Au
MG
, Kaiser
UB
, Quinton
R
, Stewart
JA
, et al. When genetic load does not correlate with phenotypic spectrum: lessons from the GnRH receptor (GNRHR)
. J Clin Endocrinol Metab
. 2012
Sep
;97
(9
):E1798
–807
.
[PubMed]
0021-972X11.
Beranova
M
, Oliveira
LM
, Bédécarrats
GY
, Schipani
E
, Vallejo
M
, Ammini
AC
, et al. Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism
. J Clin Endocrinol Metab
. 2001
Apr
;86
(4
):1580
–8
.
[PubMed]
0021-972X12.
Li
Q
, Yang
G
, Wang
Y
, Zhang
X
, Sang
Q
, Wang
H
, et al. Common genetic variation in the 3′-untranslated region of gonadotropin-releasing hormone receptor regulates gene expression in cella and is associated with thyroid function, insulin secretion as well as insulin sensitivity in polycystic ovary syndrome patients
. Hum Genet
. 2011
May
;129
(5
):553
–61
.
[PubMed]
0340-671713.
Silveira
LF
, Stewart
PM
, Thomas
M
, Clark
DA
, Bouloux
PM
, MacColl
GS
. Novel homozygous splice acceptor site GnRH receptor (GnRHR) mutation: human GnRHR “knockout”
. J Clin Endocrinol Metab
. 2002
Jun
;87
(6
):2973
–7
.
[PubMed]
0021-972X14.
Aslam
S
, Jahan
N
, Manzoor
J
. Frequency of Mutations in The GnRH Receptor Gene in Pakistani Patients With Hypogonadotropic Hypogonadism
. Pak J Zool
. 2015
Oct
;47
(5
):1219
–25
.0030-992315.
de Roux
N
, Young
J
, Brailly-Tabard
S
, Misrahi
M
, Milgrom
E
, Schaison
G
. The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred
. J Clin Endocrinol Metab
. 1999
Feb
;84
(2
):567
–72
.
[PubMed]
0021-972X16.
Kottler
ML
, Chauvin
S
, Lahlou
N
, Harris
CE
, Johnston
CJ
, Lagarde
JP
, et al. A new compound heterozygous mutation of the gonadotropin-releasing hormone receptor (L314X, Q106R) in a woman with complete hypogonadotropic hypogonadism: chronic estrogen administration amplifies the gonadotropin defect
. J Clin Endocrinol Metab
. 2000
Sep
;85
(9
):3002
–8
.
[PubMed]
0021-972X17.
Stelzer
G
, Dalah
I
, Stein
TI
, Satanower
Y
, Rosen
N
, Nativ
N
, et al. In-silico human genomics with GeneCards
. Hum Genomics
. 2011
Oct
;5
(6
):709
–17
.
[PubMed]
1473-954218.
Bhagavath
B
, Podolsky
RH
, Ozata
M
, Bolu
E
, Bick
DP
, Kulharya
A
, et al. Clinical and molecular characterization of a large sample of patients with hypogonadotropic hypogonadism
. Fertil Steril
. 2006
Mar
;85
(3
):706
–13
.
[PubMed]
0015-028219.
de Roux
N
, Young
J
, Misrahi
M
, Genet
R
, Chanson
P
, Schaison
G
, et al. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor
. N Engl J Med
. 1997
Nov
;337
(22
):1597
–602
.
[PubMed]
0028-479320.
Misbah
R
, Qaiser
M
, Maleeha
A
, Muhammad
I
, Parveen
A
, Shakeel
M
, et al. A novel mutation Ser34Phe in GNRHR causes hypogonadotropic hypogonadism during pubertal development in boys
. Pak J Zool
. 2017
Dec
;49
(1
):221
–8
.0030-992321.
Li
H
, Durbin
R
. Fast and accurate short read alignment with Burrows-Wheeler transform
. Bioinformatics
. 2009
Jul
;25
(14
):1754
–60
.
[PubMed]
1367-480322.
Wang
K
, Li
M
, Hakonarson
H
. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
. Nucleic Acids Res
. 2010
Sep
;38
(16
):e164
.
[PubMed]
0305-104823.
McKenna
A
, Hanna
M
, Banks
E
, Sivachenko
A
, Cibulskis
K
, Kernytsky
A
, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data
. Genome Res
. 2010
Sep
;20
(9
):1297
–303
.
[PubMed]
1088-905124.
Yin
H
, Ma
H
, Hussain
S
, Zhang
H
, Xie
X
, Jiang
L
, et al. A homozygous FANCM frameshift pathogenic variant causes male infertility
. Genet Med
. 2018
;(Jun
):1
.
[PubMed]
1098-360025.
Schöneberg
T
, Liu
J
, Wess
J
. Plasma membrane localization and functional rescue of truncated forms of a G protein-coupled receptor
. J Biol Chem
. 1995
Jul
;270
(30
):18000
–6
.
[PubMed]
0021-925826.
Li
Q
, Yang
G
, Wang
Y
, Zhang
X
, Sang
Q
, Wang
H
, et al. Common genetic variation in the 3′-untranslated region of gonadotropin-releasing hormone receptor regulates gene expression in cella and is associated with thyroid function, insulin secretion as well as insulin sensitivity in polycystic ovary syndrome patients
. Hum Genet
. 2011
May
;129
(5
):553
–61
.
[PubMed]
0340-6717© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
